• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Third party research

Solwers: Weak Q1 and covenant waiver concerns - Nordea

Solwers

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
Solwers' Q1 results remained weak, with profitability still at an unsatisfactory level. Net sales of EUR 21.0m came in 4% below our estimate, while adjusted EBITA of EUR 0.3m was 51% below our estimate. The company also highlighted that in March, net debt/EBITDA remained within the limits set by the covenant waiver, which is valid until the end of June 2026, but management recognises the risk that the original covenant threshold may not be met on the 30 June testing date. We believe the covenant waiver could be extended, but Solwers needs to improve its profitability clearly; the main concern is profitability, not the level of debt, we argue. Solwers guides for EBITA to improve in 2026 from EUR 1.1m in 2025; we expect EUR 3.1m. Following the Q1 report, we trim our top-line estimates by 1% for 2026-28 and cut adjusted EBITA by 5-13%. We derive a virtually unchanged DCF- and peer-based fair value range of EUR 2.6-3.0 (2.5-3.0), including EUR 0.4 per share for the present value of unannounced acquisitions.